01273 704473

info@novuscomms.com

01273 704473

info@novuscomms.com

#TSP TruSpine Technologies PLC – Subscription, Director/PDMR Dealing & RPT October 15, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has raised gross proceeds of approximately £119,344 through a subscription (the “Subscription”) for 23,869,043 new ordinary shares of 0.01p each in the Company (“Subscription Shares”) at a price of 0.5 pence per share (the “Issue Price”).   Use of Proceeds The net proceeds of the Subscription will be used to provide additional working capital for the Company as…

Continue reading

#VELA investee co. #MWE MTI Wireless Edge LTD – Interim Results and Enlargement of share buy-back programme August 21, 2024 – Posted in: Vela Technologies Plc (VELA)

MTI Wireless Edge Ltd (AIM: MWE), the technology group focused on comprehensive communication and radio frequency solutions across multiple sectors, is pleased to today announce its financial results for the six month period ended 30 June 2024.   ‘Solid H1 – well placed for continued growth’ Financial highlights ·    Revenues level at US$22.3m (H1 2023: US$22.3m) ·    18% increase in EBITDA* to US$3.3m (H1 2023: US$2.8m) ·    Profit before tax increased 10% to US$2.3m (H1…

Continue reading

#POLB Poolbeg Pharma PLC – Former Amryt Pharma Leadership Team join Poolbeg November 9, 2023 – Posted in: Blog, Poolbeg Pharma (POLB)

9 November 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announces the appointment of key former executives of Amryt Pharma plc (‘Amryt’) to its leadership team. These experienced professionals will assume pivotal roles within Poolbeg, further enhancing the Company’s expertise and capabilities. Poolbeg’s Chairman, Cathal Friel, co-founded both Poolbeg and Amryt Pharma plc. Poolbeg intends to follow a similar strategic approach to Amryt…

Continue reading